Why the study?
Does D-dimer testing help exclude the diagnosis of pulmonary embolism in patients with low clinical suspicion?
Does D-dimer testing help exclude the diagnosis of pulmonary embolism in patients with low clinical suspicion?
D-dimer testing is a highly sensitive marker useful for excluding pulmonary embolism in patients with low clinical suspicion and non-diagnostic lung scans.
May support D-dimer to exclude PE in low-suspicion nondiagnostic cases; leaves open prospective validation in current algorithms.
Pulmonary embolism is a common, yet often unsuspected and unrecognised disease associated with a high mortality. New, objective, "user friendly" and cost effective diagnostic strategies are being explored. D-dimers, the fibrinolytic degradation products of crosslinked fibrin, have emerged as the most useful of the procoagulant activity and ongoing fibrinolysis markers. D-dimer measurements are very sensitive in excluding a diagnosis of pulmonary embolism in the setting of normal values, a low clinical suspicion, and non-diagnostic lung scans. Several assays have been developed and are reviewed.
No takes yet. Share an insight, caveat, or question.
Mavromatis et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: